Kinetic oscillation stimulation for chronic migraine is associated with a significant decrease in monthly headache days vs ...

We don't think so. No matter whether you're camping or hanging out in your backyard, it's paramount that you bring protection against the wilds with bug spray. In fact, if you travel to a country ...

When the sinuses and nasal passages become inflamed, it’s known as sinusitis. Inflammation can occur because of conditions such as structural issues in the nose or a sinus infection. The terms ...

Spravato, okayed for stand-alone use among adults, is the first such therapy for major depressive disorder (MDD) that is difficult to treat.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

The company said that the nasal spray is a ketamine-derived drug, first approved in 2019, to be used in combination with antid ...

The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...